Open access journal of the Ferrata-Storti Foundation, a non-profit organization

Review Series

February 2025: Myelodysplasia

Introduction to the Review Series on Myelodysplasia (1162 Online Views)

Moshe Mittelman

https://doi.org/10.3324/haematol.2023.284948

Pathogenesis and inflammaging in myelodysplastic syndrome (2232 Online Views)

Matthew T. Villaume, Michael R. Savona

https://doi.org/10.3324/haematol.2023.284944

Diagnosis of myelodysplastic syndromes: the classic and the novel (2871 Online Views)

Howard S. Oster, Arjan A. van de Loosdrecht, Moshe Mittelman

https://doi.org/10.3324/haematol.2023.284937

Genome sequencing in the management of myelodysplastic syndromes and related disorders (2287 Online Views)

Mario Cazzola, Luca Malcovati

https://doi.org/10.3324/haematol.2023.284947

Treatment of lower-risk myelodysplastic syndromes (2656 Online Views)

Almuth Maria Anni Merz, Uwe Platzbecker

https://doi.org/10.3324/haematol.2023.284945

Treatment of high-risk myelodysplastic syndromes (2591 Online Views)

Nicolaus Kröger

https://doi.org/10.3324/haematol.2023.284946

December 2024: Venous Thromboembolism

Introduction to the Review Series on venous thromboembolism: emerging issues in pathophysiology and management (972 Online Views)

Paolo Prandoni

https://doi.org/10.3324/haematol.2024.286591

Multimorbidity, comorbidity, frailty, and venous thromboembolism (1575 Online Views)

Bengt Zöller, Jean M. Connors

https://doi.org/10.3324/haematol.2023.284579

Minor trauma and venous thromboembolism: the threshold for antithrombotic prophylaxis (1009 Online Views)

Alexandre Tran, Pamela L. Lutsey, Marc Carrier

https://doi.org/10.3324/haematol.2023.284612

Targeted anti-cancer agents and risk of venous thromboembolism (1378 Online Views)

Melina Verso, Florian Moik, Mara Graziani, Alexander T. Cohen

https://doi.org/10.3324/haematol.2023.284778

June 2024: Immunotherapy for childhood malignancies

Introduction. Immunotherapy for childhood malignancies: the future is now (1539 Online Views)

Franco Locatelli

https://doi.org/10.3324/haematol.2023.284553

Chimeric antigen receptor T-cell therapy in childhood acute myeloid leukemia: how far are we from a clinical application? (2601 Online Views)

Swati Naik, M. Paulina Velasquez, Stephen Gottschalk

https://doi.org/10.3324/haematol.2023.283817

Bispecific T-cell engagers in childhood B-acute lymphoblastic leukemia (2540 Online Views)

Kaylyn Utley Lyons, Lia Gore

https://doi.org/10.3324/haematol.2023.283818

Chimeric antigen receptor T-cell therapy for T-cell acute lymphoblastic leukemia (4123 Online Views)

Bernice L.Z. Oh, Natasha Vinanica, Desmond M.H. Wong, Dario Campana

https://doi.org/10.3324/haematol.2023.283848

Allogeneic chimeric antigen receptor T cells for children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia (2665 Online Views)

Franco Locatelli, Francesca del Bufalo, Concetta Quintarelli

https://doi.org/10.3324/haematol.2023.284604

Naked antibodies and antibody-drug conjugates: targeted therapy for childhood acute lymphoblastic leukemia (3655 Online Views)

Erica Brivio, Francisco Bautista, C. Michel Zwaan

https://doi.org/10.3324/haematol.2023.283815

December 2023: Peripheral T-Cell Lymphomas

Introduction to the peripheral T-cell lymphoma review series: advances in molecular characterization, classification refinement and treatment optimization (5704 Online Views)

Kerry J. Savage, Laurence de Leval

https://doi.org/10.3324/haematol.2023.282719

Past, present and future therapeutic approaches in nodal peripheral T-cell lymphomas (3909 Online Views)

Henry S. Ngu, Kerry J. Savage

https://doi.org/10.3324/haematol.2021.280275

Pathobiology of nodal peripheral T-cell lymphomas: current understanding and future directions (4067 Online Views)

Bettina Bisig, Kerry J. Savage, Laurence de Leval

https://doi.org/10.3324/haematol.2023.282716

Few and far between: clinical management of rare extranodal subtypes of mature T-cell and NK-cell lymphomas (2833 Online Views)

Robert Stuver, Zachary D. Epstein-Peterson, Steven M. Horwitz

https://doi.org/10.3324/haematol.2023.282717

Biology and genetics of extranodal mature T-cell and NKcell lymphomas and lymphoproliferative disorders (2338 Online Views)

Natasha E. Lewis, Ting Zhou, Ahmet Dogan

https://doi.org/10.3324/haematol.2023.282718

February 2023: Acute Myeloid Leukemia

Acute myeloid leukemia: introduction to a series highlighting progress and ongoing challenges (4275 Online Views)

Richard F. Schlenk

https://doi.org/10.3324/haematol.2022.280803

New drugs before, during, and after hematopoietic stem cell transplantation for patients with acute myeloid leukemia (9211 Online Views)

Razan Mohty, Rama El Hamed, Eolia Brissot, Ali Bazarbachi, Mohamad Mohty

https://doi.org/10.3324/haematol.2022.280798

Update on current treatments for adult acute myeloid leukemia: to treat acute myeloid leukemia intensively or non-intensively? That is the question (10863 Online Views)

Sonia Jaramillo, Richard F. Schlenk

https://doi.org/10.3324/haematol.2022.280802

Leukemic stem cells and therapy resistance in acute myeloid leukemia (18691 Online Views)

Patrick Stelmach, Andreas Trumpp

https://doi.org/10.3324/haematol.2022.280800

The clinical impact of the molecular landscape of acute myeloid leukemia (17665 Online Views)

Sabine Kayser, Mark J. Levis

https://doi.org/10.3324/haematol.2022.280801

December 2022: Measurable Residual Disease

Introduction to the Series on Measurable Residual Disease (2067 Online Views)

Jerry Radich

https://doi.org/10.3324/haematol.2022.281079

Measurable residual disease in acute lymphoblastic leukemia: methods and clinical context in adult patients (23486 Online Views)

Caner Saygin, Joseph Cannova, Wendy Stock, Lori Muffly

https://doi.org/10.3324/haematol.2022.280638

Measurable residual disease in chronic myeloid leukemia (3440 Online Views)

Susan Branford, Jane F. Apperley

https://doi.org/10.3324/haematol.2022.281493

The present and future of measurable residual disease testing in acute myeloid leukemia (8722 Online Views)

James S. Blachly, Roland B. Walter, Christopher S. Hourigan

https://doi.org/10.3324/haematol.2022.282034

June 2022: Treatment of thrombocytopenias

Introduction to a review series on the treatment of thrombocytopenic disorders: something old, something new (2553 Online Views)

Francesco Rodeghiero

https://doi.org/10.3324/haematol.2022.280920

Treatment of chemotherapy-induced thrombocytopenia in patients with non-hematologic malignancies (22910 Online Views)

David J. Kuter

https://doi.org/10.3324/haematol.2021.279512

Treatment of drug-induced immune thrombocytopenias (12667 Online Views)

Irene Marini, Gunalp Uzun, Kinan Jamal, Tamam Bakchoul

https://doi.org/10.3324/haematol.2021.279484

Treatment of inherited thrombocytopenias (4550 Online Views)

Carlo L. Balduini

https://doi.org/10.3324/haematol.2022.280856

January 2022: Indolent lymphomas

Indolent lymphomas: introduction to a series highlighting progress and ongoing challenges (3003 Online Views)

Sonali M. Smith, Gilles Salles

https://doi.org/10.3324/haematol.2021.280218

Time for an individualized approach to first-line management of follicular lymphoma (13166 Online Views)

Guillaume Cartron, Judith Trotman

https://doi.org/10.3324/haematol.2021.278766

Prospects in the management of patients with follicular lymphoma beyond first-line therapy (14712 Online Views)

David Qualls, Gilles Salles

https://doi.org/10.3324/haematol.2021.278717

Marginal zone lymphoma: present status and future perspectives (38145 Online Views)

Chan Y. Cheah, Emanuele Zucca, Davide Rossi, Thomas M. Habermann

https://doi.org/10.3324/haematol.2021.278755
What about you?

Tell us your interest and get all the new contents of haematologica in advance.

GET NOW
Navigate
For Authors
For Reviewers
For Advertisers
Education
Privacy
More
Copyright © 2025 by the Ferrata Storti Foundation | Web design ￫ | Development ￫
ISSN 0390-6078 print | ISSN 1592-8721 online